Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

16 results
Display

Beyond the survey, to the ideal therapy for Asian

Jo KJ, Im JP

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
How have treatment patterns for patients with inflammatory bowel disease changed in Asian countries?

Park J

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
JAK inhibitor, a new player for treatment-refractory microscopic colitis

Druez A, Travis S, Rahier JF

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer

Lee CH, Koh SJ, Radi ZA, Habtezion A

Inflammatory bowel disease (IBD), comprising Crohn’s disease and ulcerative colitis, is a lifelong disease that manifests with chronic intestinal inflammation, sequential fibrosis, and an increased risk of colitis-associated colon cancer...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnosis, management, and prevention of infectious complications in inflammatory bowel disease: variations among Asian countries

Baek JE, Hwang SW

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical features of enteric and colo-duodenal fistula in patients with Crohn’s disease

Lee JS, Kang SB, Park K, Yoon YS, Yu CS, Hwang SW, Ye BD, Yang SK, Lee JL, Park SH

CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Does caffeine have a double-edged sword role in inflammation and carcinogenesis in the colon?

Mizoguchi E, Sadanaga T, Okada T, Minagawa T, Akiba J

Caffeine (1,3,7-trimethylxanthine, also abbreviated to CAF) is a natural chemical with stimulant effects and is commonly included in many drinks and foods, including coffee, tea, cola, energy drinks, cocoa, chocolates,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Submucosal fat accumulation in Crohn’s disease: evaluation with sonography

Ripollés T, Martínez-Pérez MJ, Paredes JM, Vizuete J, Martin G, Navarro L

Background/Aims: The study objective is to investigate the ultrasound features that allow suspecting the presence of submucosal fat deposition, called the fat halo sign (FHS), in the intestinal wall of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions

Ahmad HA, East JE, Panaccione R, Travis S, Canavan JB, Usiskin K, Byrne MF

Inflammatory bowel disease encompasses Crohn’s disease and ulcerative colitis and is characterized by uncontrolled, relapsing, and remitting course of inflammation in the gastrointestinal tract. Artificial intelligence represents a new era...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting

Song EM, Na SY, Hong SN, Ng SC, Hisamatsu T, Ye BD

Background/Aims: As the characteristics of inflammatory bowel disease (IBD) differ between Asians and Westerners, it is necessary to determine adequate therapeutic strategy for Asian IBD patients. We evaluated the current...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD

Singh A, Gupta YK, Dhaliwal AS, Kahlon BK, Bansal V, Mahajan R, Mehta V, Singh D, Kaur R, Bansal N, Midha V, Sood A

Background/Aims: The inflammatory bowel disease (IBD)-disk is a validated, visual, 10-item, self-administered questionnaire used to evaluate IBD-related disability. The present study aimed to evaluate IBD-disk in assessment of IBD daily...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vaccination in patients with inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting

Park SB, Kim KO, Lee HS, Choi CH, Wei SC, Chen MH, Matsuoka K

Background/Aims: Long-term immunosuppressive therapies used to treat inflammatory bowel disease (IBD) are associated with an increased risk of infections, many of which can be prevented by vaccination. We assessed physicians’...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis

Giri S, Agrawal D, Afzalpurkar S, Kasturi S, Gopan A, Sundaram S, Kale A

Background/Aims: The data on the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in patients with inflammatory bowel disease (IBD) are conflicting. The present systematic review...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Infectious complications in patients with inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting

Jun YK, Koh SJ, Myung DS, Park SH, Ooi CJ, Sood A, Im JP

Background/Aims: Infectious complications are major concerns when treating patients with inflammatory bowel disease (IBD). This study evaluated clinical differences across countries/regions in the management of infectious diseases in patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Diagnosis of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting

Lee HH, Park JJ, Lee BI, Hilmi I, Sollano J, Ran ZH

Background/Aims: Inflammatory bowel disease (IBD) is no longer a rare disease in Asia, thus it needs to prepare recommendations relevant to Asian patients. This study aimed to identify disparities in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk of venous thromboembolism with a central venous catheter in hospitalized Japanese patients with inflammatory bowel disease: a propensity score-matched cohort study

Aoki Y, Kiyohara H, Mikami Y, Nanki K, Kawaguchi T, Yoshimatsu Y, Sugimoto S, Sujino T, Takabayashi K, Hosoe N, Ogata H, Iwao Y, Kanai T

Background/Aims: Thromboprophylaxis is recommended for hospitalized patients with inflammatory bowel disease (IBD) in Western countries, although it is selectively administered to high-risk patients in East Asia. A central venous catheter...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr